Patent · US Active

Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase

US9687490B2 · kind B2 · utility

0Cited by
0References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2013
Grant dateJun 27, 2017
Priority date—
Expiry dateOct 22, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D251/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula (I) for use in the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.